| scholarly article | Q13442814 |
| P50 | author | A Cheung | Q68326221 |
| Honglin Chen | Q41524644 | ||
| Jaap M Middeldorp | Q42930620 | ||
| Kwok Wai Lo | Q59247702 | ||
| P2093 | author name string | Kenzo Takada | |
| Wen Deng | |||
| Sai Wah Tsao | |||
| Ya Cao | |||
| Chi Man Tsang | |||
| Guitao Zhang | |||
| Pok Man Hau | |||
| Yim Ling Yip | |||
| Eri Seto | |||
| Cornelia Man | |||
| P2860 | cites work | Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells | Q24294987 |
| Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers | Q24561854 | ||
| Inflammation and cancer | Q24649640 | ||
| Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization | Q28243346 | ||
| Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies | Q33373662 | ||
| Elevated serum transforming growth factor beta1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM. | Q33799292 | ||
| Epstein-Barr virus and cancer | Q34297027 | ||
| Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells | Q34598541 | ||
| Epstein-Barr virus in the pathogenesis of NPC. | Q35008870 | ||
| Epstein-Barr virus: induction and control of cell transformation | Q35156683 | ||
| Virally targeted therapies for EBV-associated malignancies | Q35196601 | ||
| Epstein–Barr virus infection: basis of malignancy and potential for therapy | Q35571092 | ||
| Focus on nasopharyngeal carcinoma | Q35773862 | ||
| The inflammatory tumor microenvironment and its impact on cancer development | Q36455107 | ||
| The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells | Q36499480 | ||
| The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. | Q37114836 | ||
| Interdependence of hypoxic and innate immune responses | Q37586121 | ||
| Characterization of the Epstein-Barr virus glycoprotein BMRF-2. | Q38307961 | ||
| CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation | Q39963624 | ||
| Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40. | Q40089018 | ||
| Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection | Q40148095 | ||
| Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells | Q40209246 | ||
| Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase | Q40281326 | ||
| Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells | Q40293195 | ||
| A new method for improving metaphase chromosome spreading | Q40681246 | ||
| Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism | Q40865256 | ||
| Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. | Q45656306 | ||
| Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients. | Q45748431 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 1570-1583 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization | |
| P478 | volume | 127 |
| Q57093338 | Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells |
| Q39279923 | An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation |
| Q35079161 | Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts |
| Q40172727 | Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy. |
| Q57789222 | Connivance, Complicity, or Collusion? The Role of Noncoding RNAs in Promoting Gammaherpesvirus Tumorigenesis |
| Q36483613 | Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells |
| Q38949843 | Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma |
| Q47606332 | EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma. |
| Q92998898 | EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells |
| Q64265738 | EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the promoter |
| Q35027926 | Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study |
| Q34712473 | Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells |
| Q90481053 | Epithelial cell infection by Epstein-Barr virus |
| Q38237679 | Epstein-Barr Virus-Encoded RNAs: Key Molecules in Viral Pathogenesis |
| Q33884691 | Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity |
| Q38826798 | Epstein-Barr virus LMP1 induces focal adhesions and epithelial cell migration through effects on integrin-α5 and N-cadherin |
| Q40046633 | Epstein-Barr virus infection and nasopharyngeal carcinoma |
| Q38249886 | Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells |
| Q90003266 | Epstein-Barr virus ncRNA from a nasopharyngeal carcinoma induces an inflammatory response that promotes virus production |
| Q35476446 | Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression |
| Q35738744 | Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders |
| Q93185464 | F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model |
| Q33942005 | Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells |
| Q58089548 | Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes |
| Q45288192 | Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation |
| Q38191876 | Modes of infection and oncogenesis by the Epstein-Barr virus. |
| Q47286778 | Modulation of the Tumor Microenvironment by Epstein-Barr virus Latent Membrane Protein-1 in Nasopharyngeal Carcinoma. |
| Q38570255 | Multifunctional non-coding Epstein-Barr virus encoded RNAs (EBERs) contribute to viral pathogenesis |
| Q52347943 | New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma. |
| Q44833814 | Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. |
| Q36261589 | Prognostic value of TROP2 in human nasopharyngeal carcinoma |
| Q33850829 | RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma |
| Q35861281 | Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells. |
| Q57176933 | Role of Epstein-Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target |
| Q28235586 | SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma |
| Q40228185 | Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma |
| Q36327912 | Targeting Jab1/CSN5 in nasopharyngeal carcinoma |
| Q35598260 | Telomerase activity impacts on Epstein-Barr virus infection of AGS cells |
| Q59355701 | The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers |
| Q54245037 | The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis. |
| Q38150803 | The labyrinth of interactions of Epstein-Barr virus-encoded small RNAs. |
| Q36546506 | The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L. |
| Q38253914 | The role of Epstein-Barr virus in epithelial malignancies |
| Q38440804 | The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma |
| Q91468424 | mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma |
Search more.